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Neutrophils need just enough copies of a 
gene for an antibody-binding receptor, 
say Willcocks et al. (page 1573). Whereas 
too few copies can contribute to lupus, 
too many can predispose to vasculitis.
Cells can have as many as four copies 
of this gene, FCGR3B, which encodes 
the FcγRIIIb receptor, but some lupus 
patients have fewer than two. Willcocks 
et al. now find that this scarcity leads to 
fewer receptors on neutrophils, which 
thus fail to bind and destroy inflammation-
causing antibody clusters. The paucity 
of receptors did not impair other neu-
trophil functions such as the production 
of oxygen radicals.
Some healthy individuals also had 
fewer copies of the gene and thus simi-
larly defective neutrophils. But these 
individuals do not develop lupus, most 
likely because they lack other genetic 
defects required to cause disease. The 
compensatory influence of other genes 
might also explain why low copy 
number of FCGR3B is not a risk factor 
for lupus among all populations.
Having more FcγRIIIb receptors, 
however, doesn’t guarantee good 
health. The group found that a high 
copy number of FCGR3B was associ-
ated with vasculitis—a disease in which 
neutrophils release damaging oxygen 
radicals in response to cross-linking of 
FcγRIIIb receptors on blood vessel 
walls. 
Tumor suppressor fends off 
lung fibrosis
On page 1659, Xia et al. find 
that a protein that counters 
cancer also stops wound-healing 
fibroblasts from overdoing it.
Fibroblasts help repair 
damaged tissue by proliferat-
ing and producing collagen. 
But too much collagen can 
create scars and impair tissue 
function, as seen in patients 
with a chronic lung disease 
called idiopathic pulmonary fibrosis (IPF). Collagen normally controls its 
own levels by binding to integrins on the fibroblast surface, which triggers 
a negative feedback loop that stops the cell from proliferating further. 
In patients with IPF, according to Xia et al., this feedback loop falls apart.
The defective cog in this inhibitory loop was a tumor suppressor phos-
phatase called PTEN, which normally halts the cell cycle by inactivating 
PI3K/Akt signaling. In fibroblasts from IPF patients, however, collagen-
induced stop signals failed to activate PTEN and inhibit proliferation. In 
response to a chemical irritant, mice with reduced levels of PTEN devel-
oped unusually severe lung injury with excess collagen deposition.
Unlike certain tumors, which have low PTEN protein levels, fibro-
blasts had normal PTEN levels, but the protein failed to relocate to the 
cell membrane, where it gets activated. The defect that leads to this faulty 
localization is not yet known.
Other studies have suggested that collagen-producing cells in the 
lungs of patients with IPF are not good fibroblasts gone bad, but rather 
epithelial cells that differentiate into fibroblast-like cells in response to 
chronic exposure to TGF-β—an inflammatory cytokine that is prevalent 
in the lungs of IPF patients. 
Two paths lead to MS
Two T helper (Th) cell subsets trigger the same 
multiple sclerosis (MS)-like symptoms but 
varying disease pathologies, say Kroenke et al. 
(page 1535).
Inflammatory Th1 cells and Th17 cells can 
both drive experimental autoimmune 
encephalitis (EAE)—the mouse equivalent of MS. 
The authors found that mice injected with either 
cell type developed paralysis with the same 
speed and severity, which might suggest that 
both cell types trigger the same pathology.
A closer look at the damage, however, told a 
different tale. Mice injected with Th1 cells 
developed macrophage-filled lesions in the 
central nervous system (CNS)—a sign of 
conventional MS. But mice injected with Th17 
cells developed lesions filled with neutrophils, 
most likely in response to neutrophil-attracting 
chemokines that were produced in the CNS.
As neutrophils are highly adept at breaking 
down the blood–brain barrier, their presence 
might explain why Th17-induced lesions, 
unlike Th1-induced lesions, reached deep into 
CNS tissues. Th17 cells caused severe 
inflammation in the optic nerves and in 
sections of the spinal cord—typical of rare 
variants of MS, which do not respond to 
conventional treatment.
If similar differences are found in the 
pathology of MS, patients may benefit from 
therapies tailored to specifically inhibit the type 
of Th cell that is to blame. 
Neutrophils with fewer copies of FCGR3B 
bind poorly to IgG complexes.
PTEN deficiency increases collagen deposition 
and scarring (brown) in injured lungs.
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